Table 2.
Data and indicators for AIS patients receiving rtPA therapy at different hospital levels from 2009 to 2014 in the project of “Hospital Emergent Capability Accreditation by Level-Stroke”
| HD | MoD | MeD | Total | Overall | |
|---|---|---|---|---|---|
| Items | |||||
| 1. AIS | 94,354 (62.9) | 7,479 (5.0) | 48,088 (32.1) | 149,921 | |
| 2. Eligible for rtPA | 3,729 (57.1) | 396 (6.1) | 2,401 (36.8) | 6,526 | |
| 3. rtPA administration | 3,973 (64.2) | 430 (7.0) | 1,783 (28.8) | 6,186 | |
| 4. Qualifying for rtPA criteria | 3,567 (62.8) | 366 (6.4) | 1,749 (30.8) | 5,682 | |
| 5. Administration of rtPA within 60 min. | 2,033 (62.6) | 241 (7.4) | 973 (30.0) | 3,247 | |
| 6. SICH | 229 (43.3) | 22 (4.2) | 278 (52.6) | 529 | |
| Indicator (item no./item no.) (%) | |||||
| Treatment rate (3/1)* | 4.2†,‡ | 5.7†,§ | 3.7‡,§ | 4.1 | |
| Protocol adherence rate (4/2)† | 95.7‡,§ | 92.4‡,‖ | 72.8§,‖ | 87.1 | |
| In-time treatment rate (5/3)† | 51.2§ | 56.0 | 54.6§ | 52.5 | |
| SICH rate (6/3)† | 5.8§ | 5.1‖ | 15.6§,‖ | 8.6 |
Values are presented as n (%) unless otherwise indicated.
AIS, acute ischemic stroke; HD, heavy duty; MeD medium duty; MoD, moderate duty; min., minutes; rtPA, recombinant tissue plasminogen activator; SICH, symptomatic intracranial hemorrhage.
*
Significant differences between two groups of the index analyzed with a χ2 test with P<0.05;
†
P<0.05 HD vs. MeD;
‡
P<0.05 HD vs. MoD;
§
P<0.05 HD vs. MeD;
‖
P<0.05 MoD vs. MeD.